Takeda delivers strong first quarter fy2022 results; on track towards full-year management guidance

Osaka, japan--(business wire)--takeda (tokyo:4502/nyse:tak) today announced strong financial results for the first quarter of fiscal year 2022 (period ended june 30, 2022) and is on track to meet its full-year management guidance. the gain on the sale of takeda's japan diabetes portfolio in the first quarter of the previous fiscal year has impacted reported financial results on a year-over-year basis, as expected. the sale contributed a one-off 133 billion yen to revenue and 131.4 billion yen t
TAK Ratings Summary
TAK Quant Ranking